Cargando…

Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases

BACKGROUND: To investigate the clinical efficacy of a percutaneous “tripod” combined with radiofrequency ablation and bone cement filling surgery in treating acetabular bone metastases. METHODS: We retrospectively analyzed 11 patients who underwent percutaneous “tripod” combined with radiofrequency...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Yun, Li, Ruoyu, Jiang, Linheng, Zhou, Nannan, He, Mincon, Fang, Bin, Yi, Chunzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565971/
https://www.ncbi.nlm.nih.gov/pubmed/37817253
http://dx.doi.org/10.1186/s13018-023-04255-w
_version_ 1785118816039075840
author Lan, Yun
Li, Ruoyu
Jiang, Linheng
Zhou, Nannan
He, Mincon
Fang, Bin
Yi, Chunzhi
author_facet Lan, Yun
Li, Ruoyu
Jiang, Linheng
Zhou, Nannan
He, Mincon
Fang, Bin
Yi, Chunzhi
author_sort Lan, Yun
collection PubMed
description BACKGROUND: To investigate the clinical efficacy of a percutaneous “tripod” combined with radiofrequency ablation and bone cement filling surgery in treating acetabular bone metastases. METHODS: We retrospectively analyzed 11 patients who underwent percutaneous “tripod” combined with radiofrequency ablation and bone cement filling for acetabular bone metastases at a tertiary care hospital from February 2021 to December 2022. RESULTS: 11 cases with 13 hips underwent this procedure, including two female patients who underwent both sides, and the rest were unilateral. All cases were followed up for 3–24 months, with a mean of 12 months and a median follow-up time of 11 months. Two of the 11 patients died by the final follow-up, and nine survived. One died 7 months after surgery, and one died 8 months after surgery; the survival of the deceased patients was 7.5 months (range: 7–8 months), with a median survival time of 7.5 months. All 11 patients completed the surgery successfully, and the average unilateral operation time was 167.4 min (148–193). The amelioration of postoperative pain, concomitant with improved quality of life, was observed significantly, ultimately resulting in a prolonged and sustained effect. CONCLUSIONS: The combination of percutaneous “tripod”, radiofrequency ablation, and bone cement filling can effectively relieve pain without delaying the patient's systemic anti-tumor therapy and is a minimally invasive, safe, and effective procedure for the treatment of periacetabular metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13018-023-04255-w.
format Online
Article
Text
id pubmed-10565971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105659712023-10-12 Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases Lan, Yun Li, Ruoyu Jiang, Linheng Zhou, Nannan He, Mincon Fang, Bin Yi, Chunzhi J Orthop Surg Res Research Article BACKGROUND: To investigate the clinical efficacy of a percutaneous “tripod” combined with radiofrequency ablation and bone cement filling surgery in treating acetabular bone metastases. METHODS: We retrospectively analyzed 11 patients who underwent percutaneous “tripod” combined with radiofrequency ablation and bone cement filling for acetabular bone metastases at a tertiary care hospital from February 2021 to December 2022. RESULTS: 11 cases with 13 hips underwent this procedure, including two female patients who underwent both sides, and the rest were unilateral. All cases were followed up for 3–24 months, with a mean of 12 months and a median follow-up time of 11 months. Two of the 11 patients died by the final follow-up, and nine survived. One died 7 months after surgery, and one died 8 months after surgery; the survival of the deceased patients was 7.5 months (range: 7–8 months), with a median survival time of 7.5 months. All 11 patients completed the surgery successfully, and the average unilateral operation time was 167.4 min (148–193). The amelioration of postoperative pain, concomitant with improved quality of life, was observed significantly, ultimately resulting in a prolonged and sustained effect. CONCLUSIONS: The combination of percutaneous “tripod”, radiofrequency ablation, and bone cement filling can effectively relieve pain without delaying the patient's systemic anti-tumor therapy and is a minimally invasive, safe, and effective procedure for the treatment of periacetabular metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13018-023-04255-w. BioMed Central 2023-10-11 /pmc/articles/PMC10565971/ /pubmed/37817253 http://dx.doi.org/10.1186/s13018-023-04255-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lan, Yun
Li, Ruoyu
Jiang, Linheng
Zhou, Nannan
He, Mincon
Fang, Bin
Yi, Chunzhi
Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title_full Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title_fullStr Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title_full_unstemmed Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title_short Clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
title_sort clinical efficacy analysis of percutaneous “tripod” combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565971/
https://www.ncbi.nlm.nih.gov/pubmed/37817253
http://dx.doi.org/10.1186/s13018-023-04255-w
work_keys_str_mv AT lanyun clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT liruoyu clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT jianglinheng clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT zhounannan clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT hemincon clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT fangbin clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases
AT yichunzhi clinicalefficacyanalysisofpercutaneoustripodcombinedwithradiofrequencyablationandbonecementfillinginthetreatmentofperiacetabularmetastases